网站综合信息 xanodyne.com
    • 标题:
    • Xanodyne Pharmaceuticals Inc. 
    • 关键字:
    • Zipsor Lysteda Pain Management Womens Health Oramorph 
    • 描述:
    • Xanodyne Pharmaceuticals, Inc., founded in 2001, is an integrated specialty pharmaceutical company w 
    • 域名信息
    • 域名年龄:23年10个月21天  注册日期:2001年03月31日  到期时间:2018年03月31日
      邮箱:abuse  电话:+61.386242300
      注册商:MELBOURNE IT, LTD. D/B/A INTERNET NAMES WORLDWIDE 
    • 备案信息
    • 备案号: 
    网站收录SEO数据
    • 搜索引擎
    • 收录量
    • 反向链接
    • 其他
    • 百度
    • 0  
    • 409  
    • 快照:无首页快照  
    • Google
    • 51  
    • 11  
    • pr:4  
    • 雅虎
    • 0  
    •  
    •  
    • 搜搜
    • 0  
    •  
    •  
    • 搜狗
    • 1  
    •  
    • 评级:1/10  
    • 360搜索
    • 0  
    •  
    •  
    域名流量Alexa排名
    •  
    • 一周平均
    • 一个月平均
    • 三个月平均
    • Alexa全球排名
    • -  
    • 平均日IP
    • 日总PV
    • 人均PV(PV/IP比例)
    • 反向链接
    • dmoz目录收录
    • Business/Biotechnology_and_Pharmaceuticals/Pharmaceuticals/Manufacturing  

    • 流量走势图
    域名注册Whois信息

    xanodyne.com

    域名年龄: 23年10个月21天
    注册时间: 2001-03-31
    到期时间: 2018-03-31
    注 册 商: MELBOURNE IT, LTD. D/B/A INTERNET NAMES WORLDWIDE
    注册邮箱: abuse
    联系电话: +61.386242300

    获取时间: 2014年04月11日 17:53:09
    Domain Name: XANODYNE.COM
    Registrar: MELBOURNE IT, LTD. D/B/A INTERNET NAMES WORLDWIDE
    Whois Server: whois.melbourneit.com
    Referral URL: http://www.melbourneit.com
    Name Server: NS.SITEPROTECT.COM
    Name Server: NS2.SITEPROTECT.COM
    Status: clientTransferProhibited
    Updated Date: 2009-02-13
    Creation Date: 2001-03-31
    Expiration Date: 2018-03-31

    >>> Last update of whois database: Fri, 2014-Apr-11 09:57:14 UTC <<<

    Domain Name: xanodyne.com
    Registry Domain ID: 68641876_DOMAIN_COM-VRSN
    Registrar WHOIS Server: whois.melbourneit.com
    Registrar URL: http://www.melbourneit.com.au
    Updated Date: 2009-02-13T15:43:30Z
    Creation Date: 2001-03-31T12:38:47Z
    Registrar Registration Expiration Date: 2018-03-31T11:38:47Z
    Registrar: Melbourne IT Ltd
    Registrar IANA ID: 13
    Registrar Abuse Contact Email: abuse
    Registrar Abuse Contact Phone: +61.386242300
    Domain Status: clientTransferProhibited
    Registry Registrant ID:
    Registrant Name: Xanodyne Pharmaceuticals
    Registrant Organization: Xanodyne Pharmaceuticals
    Registrant Street: One Riverfront Plac Suite 900
    Registrant City: Newport
    Registrant State/Province: KY
    Registrant Postal Code: 41071
    Registrant Country: US
    Registrant Phone: +1.8593716383
    Registrant Phone Ext:
    Registrant Fax: +1.8886636648
    Registrant Fax Ext:
    Registrant Email: jpowell
    Registry Admin ID:
    Admin Name: Joseph Powell
    Admin Organization:
    Admin Street: One Riverfront Place Suite 900
    Admin City: Newport
    Admin State/Province: KY
    Admin Postal Code: 41071
    Admin Country: US
    Admin Phone: +1.8593716383
    Admin Phone Ext:
    Admin Fax: +1.8593716391
    Admin Fax Ext:
    Admin Email: jpowell
    Registry Tech ID:
    Tech Name: Joseph Powell
    Tech Organization:
    Tech Street: One Riverfront Place Suite 900
    Tech City: Newport
    Tech State/Province: KY
    Tech Postal Code: 41071
    Tech Country: US
    Tech Phone: +1.8593716383
    Tech Phone Ext:
    Tech Fax: +1.8593716391
    Tech Fax Ext:
    Tech Email: jpowell
    Name Server: NS.SITEPROTECT.COM
    Name Server: NS2.SITEPROTECT.COM
    DNSSEC: unsigned
    URL of the ICANN WHOIS Data Problem Reporting System: http://wdrprs.internic.net
    >>> Last update of WHOIS database: 2014-04-11T09:47:26Z

    TERMS OF USE OF MELBOURNE IT WHOIS DATABASE
    The WHOIS database is operated by Melbourne IT Ltd ('we', 'our' or 'us'). Your access to, and use of, our WHOIS database and the information made available on our WHOIS database is subject to these Terms of Use and our Privacy Policy. All information contained in our WHOIS database is provided 'as is'. We take no responsibility for any error or omission in our WHOIS database. The data in our WHOIS database is provided to you for your information only. You may use the information in our WHOIS database only for the purpose of obtaining information about or related to a domain name registration record ('Permitted Purpose'). You agree not to use high-volume, automated electronic processes to access or query our WHOIS database. By submitting a WHOIS query to us, you agree that you will only use the data obtained from a WHOIS query for the Permitted Purpose and for lawful purposes, and that you will not: (a) allow, enable, or otherwise support the transmission of mass, unsolicited, commercial advertising or solicitations by e-mail, telephone, or facsimile; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of any Registry Operator or ICANN-Accredited registrar, except as reasonably necessary to register domain names or modify existing domain name registrations. You also agree that the copying, reprod
    其他后缀域名
    • 顶级域名
    • 相关信息
    网站首页快照(纯文字版)
    抓取时间:2019年05月22日 07:57:45
    网址:http://xanodyne.com/
    标题:Xanodyne Pharmaceuticals Inc.
    关键字:Zipsor, Lysteda, Pain Management, Womens Health, Oramorph
    描述:Xanodyne Pharmaceuticals, Inc., founded in 2001, is an integrated specialty pharmaceutical company with both development and commercial capabilities …
    主体:
    HOME   •   PRIVACY   •   DIRECTIONS
    ABOUT US
    PRODUCTS
    PIPELINE
    NEWSROOM
    CAREERS
    CONTACT US
    Company News & Announcements
    May 16, 2011
    Xanodyne Pharmaceuticals Appoints New Chief Operating Officer
    May 27, 2010
    XANODYNE ANNOUNCES PLANNED PRESIDENT & CEO SUCCESSION
    May 7, 2010
    XANODYNE ANNOUNCES RENEWED FOCUS ON PAIN MANAGEMENT MARKET
    [ Corporate Governance ]
    Welcome to Xanodyne
    Xanodyne Pharmaceuticals, Inc., founded in 2001, is an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management. We market a portfolio of prescription pharmaceuticals and a line of prenatal vitamins, and we are advancing a late stage pipeline of product candidates targeted at significant potential markets in pain management.
    Product Withdrawal: Xanodyne agrees to withdraw Propoxyphene from US market.
    Recently Approved: Zipsor® for the treatment of mild to moderate acute pain in adults was approved by the FDA on June 16, 2009.  
    We are Developing: XP21B for the treatment of acute pain is in Phase 2 development.
    Product Highlights
    Zipsor®
    Zipsor® is the first liquid filled capsule NSAID with ProSorb® technology indicated for mild to moderate acute pain in adults (18 years or older)... [MORE]
    Zipsor®
    Zipsor® is the first liquid filled capsule NSAID with ProSorb® technology indicated for mild to moderate acute pain in adults (18 years or older)... [MORE]
    Zipsor®
    Zipsor® is the first liquid filled capsule NSAID with ProSorb® technology indicated for mild to moderate acute pain in adults (18 years or older)... [MORE]

    © 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询

    2025-02-09 05:37, Process in 0.0070 second.